The explosion of interest in induced pluripotent stem cells has been fueled by their potential as a limitless source of cells to repair damaged tissues in any number of diseases. However, generating cells is only a small part of the problem; ensuring that these cells integrate into their new environment and function appropriately is now a more pressing challenge. In this issue's Select, we focus on four recent papers that tackle this problem and find that new ways to stimulate endogenous regeneration are providing promising alternatives to restore organ function.
Differentiation Drug Reconstructs Cartilage
For cases in which endogenous stem cells are present and intact in the damaged organ, simply nudging these cells to differentiate into the desired tissue type may be all that is required. Schultz and coworkers take this approach, with the aim of repairing damaged cartilage in mouse models of osteoarthritis. Current therapies for this debilitating joint disease are limited to surgery and pain management. Attempts to slow or reverse disease progression with drugs have so far focused on protecting cartilage-producing chondrocytes from inflammatory damage or inhibiting matrix-degrading enzymes. However, so far, these approaches have met with limited success. The authors instead screen a library of 22,000 small molecules for their ability to promote differentiation of mesenchymal stem cells into chondrocytes in vitro. One molecule, which they named kartogenin, not only stimulates chondrocyte differentiation, but also appears to protect mature chondrocytes from inflammatory cytokines. When tested in two different osteoarthritis models, kartogenin promotes regeneration of the cartilage matrix and significantly reduces levels of pain, with no obvious side effects. Using crosslinking, the team identified filamin A as the cellular target and went on to define the mechanism by which kartogenin stimulates cartilage repair. Interaction with the drug prevents filamin A from binding and sequestering CBFb, a cofactor of the RUNX family of transcription factors. Strikingly, 5 of the 39 genes identified in a microarray analysis of gene expression changes induced by kartogenin are known targets of RUNX1, and knocking down CBFb or RUNX1 prevents kartogenin from stimulating chondrocyte differentiation. Together, the findings suggest that kartogenin, through its effects on chondrocyte differentiation and survival, may be a valuable component in a multipronged strategy to combat osteoarthritis. Johnson, K., et al. (2012 Cells isolated from hearts injected with the reprogramming factors. The green cell represents a pre-existing cardiomyocyte, and the yellow cells represent newly born induced cardiomyocytes.
Therapies for rheumatoid arthritis are currently limited to pain management and surgery.
A Cytokine for Immune Recovery
The thymus is endowed with an innate capacity to regenerate, and this property is critical in patients recovering from treatments involving cytotoxic drugs or irradiation, such as those undergoing cancer chemotherapy or hematopoietic stem cell transplants. However, in old age, thymic regeneration can be impaired, leaving elderly patients with a weakened adaptive immune system and a high risk of infection. Understanding the mechanisms of thymic renewal may provide vital clues as to how to accelerate this process. Van den Brink and colleagues identify a cytokine cascade that stimulates proliferation of thymic epithelial cells. Mice that are unable to produce IL-22 fail to regenerate the thymus following total body irradiation (TBI), and treatment of irradiated wildtype mice with IL-22 accelerates thymic recovery. Searching for the source of IL-22, the authors identify a specialized population of RORg(t)-positive innate lymphoid cells in the thymus, known as lymphoid tissue inducer cells. Mice lacking RORg(t) have normal levels of IL-22 under basal conditions but fail to increase IL-22 production in response to thymic injury. Tracing further back through the mechanism, the authors show that inducer cells are stimulated by IL-23 secreted by dendritic cells in the thymus. It remains unclear how this cascade is triggered by thymic injury, but several results suggest that dendritic cells respond specifically to the number of CD4+CD8+ double-positive thymocytes present. Halting T cell development prior to the double-positive stage promotes IL-22 production; however, a block at the later single-positive stage has no effect. Levels of IL-22 and IL-23 inversely correlate with the number of double-positive cells present, and selective killing of double-positive T cells with dexamethasone stimulates IL-22 secretion by innate lymphoid cells. It remains to be seen how this counting mechanism operates, but the therapeutic implications of the study are already clear: IL-22 may provide an effective means of boosting thymic regeneration in vulnerable patients. Dudakov, J. A., et al. (2012) . Science 336, [91] [92] [93] [94] [95] 
Restoring Sight
Its relative ease of access and immune privileged status have made the retina one of the most promising targets for cell-based therapies, with phase I clinical trials of retinal pigment epithelium already well underway for the treatment of an inherited form of visual impairment. However, the transplantation of photoreceptors poses a distinct challenge in that new photoreceptor cells must integrate and form functional synapses with endogenous neurons. A key question is therefore whether cell transplantation will ever be capable of restoring sight. Ali and coworkers provide convincing evidence that suggests that we have every reason to be optimistic. They take advantage of a mouse model of congenital night blindness in which the retina lacks functional rod cells that are necessary for vision in low light conditions. By improving their transplantation protocols, they succeed in transferring 20-30 times more cells than previous attempts. Although the transplanted neurons are responsive to light, electroretinograms, which measure the retinal response more globally, fail to detect any improvement in sensitivity over a period of 6 weeks. Despite this, low light stimuli generate a robust response in the visual cortex, consistent with the idea that retinal signals are significantly amplified as they transit through the visual pathway. Most excitingly, treated mice displayed clear signs of functional vision in a number of behavioral tests under low light, including a water maze test that requires cognitive processing of visual information. The best-performing animals had the largest number of transplanted cells, with areas of higher density being particularly important. These findings suggest that recovery of as little as 1% of rod function is sufficient to restore some degree of functional vision. If further improvements in transplantation efficiency are achievable, the future may indeed be bright. Pearson, R.A., et al. (2012) . Nature. Published online April 18, 2012 April 18, . 10.1038 .
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A cascade of cytokines links double-positive thymocyte number to thymic epithelial regeneration.
Integrated rod photoreceptor cells (green) following subretinal injection of rod photoreceptor precursors into an adult mouse.
